Evidence map›Paper›PMID 33060677›Full record

ArticleScientific reports2020

SHIFT: speedy histological-to-immunofluorescent translation of a tumor signature enabled by deep learning.

Erik A Burlingame, Mary McDonnell, Geoffrey F Schau, Guillaume Thibault, Christian Lanciault, Terry Morgan, Brett E Johnson, Christopher Corless, Joe W Gray, Young Hwan Chang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Single color digital H&E staining with In-and-Out Net.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Erik A BurlingameComputational Biology Program, Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Mary McDonnellOHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Geoffrey F SchauComputational Biology Program, Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Guillaume ThibaultOHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Christian LanciaultDepartment of Pathology, Oregon Health and Science University, Portland, OR, USA.
Terry MorganDepartment of Pathology, Oregon Health and Science University, Portland, OR, USA.
Brett E JohnsonOHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Christopher CorlessKnight Diagnostic Laboratories, Oregon Health and Science University, Portland, OR, USA.
Joe W GrayOHSU Center for Spatial Systems Biomedicine, Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Young Hwan ChangComputational Biology Program, Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA. chanyo@ohsu.edu.
Oregon Health & Science University · US

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Understanding the Impact of Microscale and Nanoscale Heterogeneity and ResistanceU54CA209988 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GRAY, JOE W. · 2017 to 2021
$10.3M
Omic and Multidimensional Spatial Atlas of Metastatic Breast CancerU2CCA233280 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI DEMIR, EMEK, MILLS, GORDON B. · 2018 to 2023
$9.7M
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimensU01CA224012 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI BRODY, JONATHAN, COUSSENS, LISA M. · 2019 to 2023
$2.9M
EPA EP-C-17-031NCI NIH HHS P30 CA069533NCI NIH HHS U01 CA224012NCI NIH HHS U2C CA233280NCI NIH HHS U54 CA209988NCI NIH HHS U54CA209988
6 · The paper itself

Abstract

Spatially-resolved molecular profiling by immunostaining tissue sections is a key feature in cancer diagnosis, subtyping, and treatment, where it complements routine histopathological evaluation by clarifying tumor phenotypes. In this work, we present a deep learning-based method called speedy histological-to-immunofluorescent translation (SHIFT) which takes histologic images of hematoxylin and eosin (H&E)-stained tissue as input, then in near-real time returns inferred virtual immunofluorescence (IF) images that estimate the underlying distribution of the tumor cell marker pan-cytokeratin (panCK). To build a dataset suitable for learning this task, we developed a serial staining protocol which allows IF and H&E images from the same tissue to be spatially registered. We show that deep learning-extracted morphological feature representations of histological images can guide representative sample selection, which improved SHIFT generalizability in a small but heterogenous set of human pancreatic cancer samples. With validation in larger cohorts, SHIFT could serve as an efficient preliminary, auxiliary, or substitute for panCK IF by delivering virtual panCK IF images for a fraction of the cost and in a fraction of the time required by traditional IF.

Indexed as

Deep LearningActinsAgedAlgorithmsBiomarkers, TumorColoring AgentsFemaleHumansImage Processing, Computer-AssistedKeratinsMicroscopy, FluorescenceMiddle AgedPancreatic NeoplasmsPhenotypeStaining and LabelingActinsBiomarkers, TumorColoring AgentsKeratins

Identifiers

PMID33060677
PMCPMC7566625
OpenAlexW3093095586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.